Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

Invesco Pharmaceuticals ETF shows a stronger 5-year growth total of $1,563 versus $1,480 for the First Trust NYSE Arca Biotechnology Index Fund, a $83 (about 5.6%) difference. This is a relative performance update without broader company or policy implications.

Analysis

Invesco Pharmaceuticals ETF shows a stronger 5-year growth total of $1,563 versus $1,480 for the First Trust NYSE Arca Biotechnology Index Fund, a $83 (about 5.6%) difference. This is a relative performance update without broader company or policy implications.